Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
Vietnam Pharmacy Retail Market, By Market Structure (Organized v/s Unorganized), By Product Type (Prescribed Drugs, Over-the-Counter Products, Non-Pharmaceutical Products, Medical Equipment), By Therapeutic Area (Cardiovascular, Anti-Diabetic, Pain Relief/Analgesics, Vitamins/Minerals/Nutrients, Anti-Infective, Others), By Drug Type (Generic v/s Patented), By Pharmacy Location (Street/Mall Based v/s Hospital Based), By Region, Competition Forecast & Opportunities, 2017-2027
... v/s Patented), By Pharmacy Location (Street/Mall Based v/s Hospital Based), By Region, Competition Forecast & Opportunities, 2017-2027 Vietnam pharmacy retail market is projected to grow at a significant rate during the forecast period. The market ... Read More
-
South Korea VR In Healthcare Market Forecast 2022-2028
... the market’s study is 2021, and the forecasted years are from 2022 to 2028. Some of the key factors influencing the country’s market growth include the increasing technological developments and innovations as well as the ... Read More
-
Global Neurology Patient Monitoring Market Size study, by Application (Trauma, CSF Management, Migraine, Stroke, Hydrocephalus, EEG, Others), and Regional Forecasts 2022-2028
... and is anticipated to grow with a healthy growth rate of more than 7.0 % over the forecast period 2022-2028. Neurology Patient Monitoring is basically providing an opportunity to treat and diagnose patients facing neurological ... Read More
-
Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication (Pain Management, Oncology, CNS Condition, Diabetes, Obesity), By Region, And Segment Forecasts, 2022 - 2030
... by Grand View Research, Inc. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed ... Read More
-
Pain Management Devices Market Size, Share & Trends Analysis Report By Product (RFA, Neurostimulation), By Application (Neuropathic Pain, Cancer), By Region (APAC, North America), And Segment Forecasts, 2022 - 2030
... new report by Grand View Research, Inc. Increasing prevalence of chronic pain and technological advancements are driving the market growth. The rising prevalence of chronic diseases, coupled with the increasing geriatric population, across the globe ... Read More
-
Global Non-opioid Pain Patches Market Size study, by Product Type (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies) and Regional Forecasts 2022-2028
... Regional Forecasts 2022-2028 Global Non-opioid Pain Patches Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period ... Read More
-
Global Pelvic Floor Diagnostics Market Size study, by Product (Urodynamics Systems, Uroflowmetry Devices, Anal Manometry Systems, Cystoscopes, Ultrasound Systems, Electromyography (EMG)) by end use industries (Hospitals, Diagnostic Imaging Centres, Specialty Clinics) and Regional Forecasts 2022-2028
... Global Pelvic Floor Diagnostics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Pelvic floor ... Read More
-
South and Central America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The South and Central America pharmacogenomics market is expected to reach US$ 591.35 million by 2028 from US$ ... Read More
-
Europe Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Europe pharmacogenomics market is expected to reach US$ 3,874.31 million by 2028 from US$ 1,962.48 million in 2021. It is ... Read More
-
Middle East and Africa Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Middle East and Africa pharmacogenomics market is expected to reach US$ 427.68 million by 2028 from US$ ... Read More
-
North America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The North America pharmacogenomics market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. ... Read More
-
U.S. Ambulatory Surgery Centers Market Size, Share & Trends Analysis Report By Application (Orthopedics, Pain Management/Spinal Injections), And Segment Forecasts, 2022 - 2030
... centers market size is expected to reach USD 58.6 billion by 2030, expanding at a CAGR of 5.9%, according to a new report by Grand View Research, Inc. The cost-effectiveness of procedures performed at ASCs ... Read More
-
2022 Global Forecast for Veterinary Pain Management (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Asia Pacific Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Asia Pacific pharmacogenomics market is expected to reach US$ 2,679.64 million by 2028 from US$ 1,148.36 million in 2021. ... Read More
-
Leading Intrathecal Pumps Country Markets Databank
... 2029. Asia-Pacific is expected to be the highest contributor to this market, with $59.2 Million in 2020, and is anticipated to reach $177.4 Million by 2029, registering a CAGR of 13.02%. Asia-Pacific and North America ... Read More
-
Insomnia Market By Therapy Type (Non pharmacological Therapy, Pharmacological Therapy): Global Opportunity Analysis and Industry Forecast, 2020-2030
... 6,315.9 million by 2030, registering a CAGR of 3.9% from 2021 to 2030. Insomnia is a sleep disorder wherein people find it difficult to sleep or remain asleep. The symptoms for insomnia include, low stamina, ... Read More
-
Leading Minor Cannabinoids Country Markets Databank
... 2029. Asia-Pacific is expected to be the highest contributor to this market, with $2,718.5 Million in 2020, and is anticipated to reach $5,888.3 Million by 2029, registering a CAGR of 9.01%. Asia-Pacific and North America ... Read More
-
Europe Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
-
North America Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Asia-Pacific Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
North America Minor Cannabinoids Market Databank
... 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid ... Read More
-
Global Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Leading Intrathecal Pumps Type Markets Databank
... 2029. Baclofen segment is expected to be the highest contributor to this market, with $65.3 Million in 2020, and is anticipated to reach $181.1 Million by 2029, registering a CAGR of 12.05%. Baclofen and Bupivacaine ... Read More
-
Cannabidiol (CBD) Market Size By Product (Oil, Tinctures, Suppository, Transdermal Patches, Isolates, Tablet, Capsules, Vape Oil, Creams And Roll-On, CBD Inhalers), By Application (Anxiety/Stress, Sleep/Insomnia, Chronic Pain, Migraine, Skin Care, Seizures, Joint Pain & Inflammation, Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacy, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacy, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, ... Read More
-
Global Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
Research Assistance
